Niki BioSolutions annual r&d spending
2017
2018
2019
2020
2021
2022
2023
2024
2025
Niki BioSolutions R&D Spending Growth & History (NIKI)
Niki BioSolutions's r&d spending was $352,879 for fiscal 2025.
View full Niki BioSolutions company overviewNiki BioSolutions annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $352,879 | −$1.8M | −83.92% |
| 2024 | 2024-12-31 | $2.2M | −$3.0M | −57.77% |
| 2023 | 2023-12-31 | $5.2M | −$4.0M | −43.62% |
| 2022 | 2022-12-31 | $9.2M | −$1.7M | −15.18% |
| 2021 | 2021-12-31 | $10.9M | −$717,281 | −6.19% |
| 2020 | 2020-12-31 | $11.6M | $4.6M | +66.98% |
| 2019 | 2019-12-31 | $6.9M | $3.8M | +123.74% |
| 2018 | 2018-12-31 | $3.1M | $541,109 | +21.13% |
| 2017 | 2017-12-31 | $2.6M | — | — |
Niki BioSolutions quarterly r&d spending
Q3.24
Q4.24
Q3.25
Q4.25
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $91,711 | $376,177 | — |
| Q3 2025 | 2025-09-30 | $241,793 | −$198,911 | −45.13% |
| Q4 2024 | 2024-12-31 | −$284,466 | — | — |
| Q3 2024 | 2024-09-30 | $440,704 | — | — |
Niki BioSolutions r&d spending trends
Over the last five fiscal years, Niki BioSolutions's r&d spending decreased from $11.6M to $352,879, a change of −$11.2M. The latest reported quarter, Q4 2025, shows $91,711.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Niki BioSolutions source filings ↗